COMMUNIQUÉS West-GlobeNewswire

Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5
22/04/2026
CHARLOTTE, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on [...]
Altimmune Announces Proposed Underwritten Public Offering of Securities
22/04/2026
GAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced it has [...]
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
22/04/2026
HOUSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous [...]
Sight Sciences Announces the Release of its Sustainability Report
22/04/2026
The Sustainability Report provides data for 2023 through 2025 on the Company’s environmental, social, and governance initiatives MENLO PARK, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT [...]
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
22/04/2026
STAFFORD, Texas, April 22, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous intracerebral hemorrhage
22/04/2026
Significant lowering of systolic blood pressure of 9mmHg on top of background treatment maintained with GMRx2 over an average follow-up of 3 years Safety findings similar to previous studies of GMRx2 London, UK, Boston [...]
Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée
22/04/2026
Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée Approbation pour les [...]
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
22/04/2026
Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria Approval for children aged two to 11 years with CSU who remain [...]
Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
22/04/2026
Approval for children aged 2 to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical trial program CSU is a chronic skin disease that causes [...]
Mind Lab Pro Unveiled: Does This “Universal Nootropic” Really Improve Focus, Memory & Brain Power? Read Mind Lab PRO Report!
22/04/2026
Explore Mind Lab Pro’s science-backed formula, clinical insights & cognitive benefits. A complete guide to focus, memory & brain performance. New York City, NY, April 22, 2026 (GLOBE NEWSWIRE) -- In an era where [...]
Romeo Orthopaedics Welcomes Lauren Hennessy, MPAS, PA‑C, to Their Esteemed Team
22/04/2026
Lauren Hennessy Joins Romeo Orthopaedics to Support Specialized Care for Shoulder and Elbow Conditions Burr Ridge, ILLINOIS, April 22, 2026 (GLOBE NEWSWIRE) -- Romeo Orthopaedics, a leader in specialized care for [...]
MedShop Direct Expands White Glove Delivery and Installation of Adjustable Medical Beds for Assisted Living and Home Care Across 48 States
22/04/2026
Houston, TEXAS, April 22, 2026 (GLOBE NEWSWIRE) -- MedShop Direct , an online supplier of assisted living and home care beds, announced today the expansion of its white-glove delivery and professional in-home [...]
Coloplast A/S - H1 2025/26 Earnings Release - Invitation for conference call on 12 May 2026 at 11:00 CEST
22/04/2026
Tuesday, 12 May 2026 at 11:00 - 12:00 CEST In connection with the publication of Coloplast’s interim financial results for H1 2025/26, to be released same day around 07:30 CEST, Coloplast will host a conference call to [...]
Providence Saint John’s Study Finds Lifestyle Program Improves Brain Health in Patients with Early Cognitive Impairment
22/04/2026
Findings suggest clinically delivered lifestyle programs may support cognitive health in people with Alzheimer’s-related brain changes SANTA MONICA, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Researchers from the [...]
Ipsen S.A. - Informations concernant la tenue de l’Assemblée Générale Mixte du 13 mai 2026
22/04/2026
Informations concernant la tenue de l’Assemblée Générale Mixte du 13 mai 2026 d’Ipsen S.A. Modalités de mise à disposition et de consultation des documents préparatoires à l’Assemblée PARIS, FRANCE, 22 AVRIL 2026 - [...]
Ipsen S.A. - Information relating to the holding of the Combined Shareholders’ Meeting of 13 May 2026
22/04/2026
Information relating to the holding of the Combined Shareholders’ Meeting of 13 May 2026 of Ipsen S.A. Formalities for making available and consulting preparatory documents to the Meeting PARIS, FRANCE, 22 APRIL 2026 - [...]
EssilorLuxottica: Chiffre d'affaires T1 2026 - Chiffre d'affaires en hausse de +10,8 % au premier trimestre. Troisième trimestre consécutif de croissance à deux chiffres
22/04/2026
Chiffre d'affaires en hausse de +10,8 % au premier trimestre Troisième trimestre consécutif de croissance à deux chiffres Chiffre d'affaires du Groupe à 7 127 millions d'euros au T1, en hausse de +10,8 % à taux de [...]
EssilorLuxottica: Q1 2026 Revenue - Revenue rising 10.8% in Q1. Third consecutive quarter of double-digit growth
22/04/2026
Revenue rising 10.8% in Q1 Third consecutive quarter of double-digit growth Group revenue at Euro 7,127 million in Q1, up 10.8% at constant exchange rates 1 and +4.1% at current rates Both Professional Solutions and [...]
LIfT BioSciences Announces Publication of Review Article in Frontiers in Immunology Highlighting Broad Therapeutic Potential of Neutrophils and IMANs in Cancer
22/04/2026
Neutrophils, long considered short-lived immune cells, can be therapeutically targeted when their appropriate subset and functional state are identified for the disease context LIfT BioSciences’ immunomodulatory alpha [...]

Pages